Literature DB >> 28676157

Mohs Micrographic Surgery for the Management of Cutaneous Malignancies.

Bobbak Mansouri1, Lindsay M Bicknell1, Dane Hill1, Gregory D Walker1, Katherine Fiala2, Chad Housewright1.   

Abstract

Mohs micrographic surgery is a specialized form of skin cancer surgery in which the Mohs surgeon acts as both surgeon and pathologist. The procedure is characterized by its histopathologic margin control and ability to spare tissue, particularly in cosmetically sensitive locations. Mohs surgery is known for both limiting the size of the final defect and its high cure rate. In this review, the authors highlight indications for the procedure, detail the technique itself, discuss cutaneous tumors for which Mohs micrographic surgery is indicated, and present the economic benefit of Mohs surgery. Published by Elsevier Inc.

Entities:  

Keywords:  Appropriate use criteria; Mohs; Mohs micrographic surgery; Skin cancer

Mesh:

Year:  2017        PMID: 28676157     DOI: 10.1016/j.fsc.2017.03.002

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN: 1064-7406            Impact factor:   1.918


  3 in total

1.  Cancer worry after facial nonmelanoma skin cancer resection and reconstruction: A 1-year prospective study.

Authors:  Lucy J van Hensbergen; Inge J Veldhuizen; Erica H Lee; Saskia Houterman; Tjinta Brinkhuizen; René R W J van der Hulst; Maarten M Hoogbergen
Journal:  Psychooncology       Date:  2021-09-14       Impact factor: 3.955

2.  Retrospective evaluation of the utility of two-step surgery for facial basal cell carcinoma and squamous cell carcinoma.

Authors:  Shiro Iino; Natsuki Baba; Takumi Hasegawa; Hiroshi Kasamatsu; Noritaka Oyama; Takahiro Tokunaga; Minoru Hasegawa
Journal:  Front Surg       Date:  2022-09-07

3.  Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort.

Authors:  C Nätterdahl; J Kappelin; B Persson; K Lundqvist; I Ahnlide; K Saleh; Å Ingvar
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-04-12       Impact factor: 9.228

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.